Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 8.6B | 10.6B | 8.0B | 7.6B |
Cost of revenue | 7.9B | 7.8B | 5.6B | 7.0B |
Gross profit | 688M | 2.8B | 2.4B | 637M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 220M | 224M | 203M | 201M |
Operating income | 280M | 405M | 307M | 256M |
Non operating interest income | ||||
Income | 9M | 8M | 1M | 10M |
Expense | 43M | 49M | 52M | 46M |
Other income expense | — | — | — | — |
Pretax income | 209M | 329M | 250M | 245M |
Tax provision | 47M | -75M | 58M | 54M |
Net income | 162M | 253M | 192M | 192M |
Basic EPS | — | 2.3 | 1.7 | 1.7 |
Diluted EPS | — | 2.2 | 1.7 | 1.7 |
Basic average shares | — | 1.3B | 1.3B | 1.3B |
Diluted average shares | — | 1.3B | 1.3B | 1.3B |
EBITDA | 440M | 609M | 487M | 471M |
Net income from continuing op. | 209M | 329M | 250M | 245M |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |